Clinical Trial Detail

NCT ID NCT02529072
Title Nivolumab With DC Vaccines for Recurrent Brain Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Gary Archer Ph.D.
Indications

astrocytoma

malignant glioma

Therapies

Nivolumab

Age Groups: adult

No variant requirements are available.